Lattice Semiconductor Corp
LSCCNasdaqCIK 855658TechnologyFiscal year ends Jan 2
Reports and events: 304 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-04-2821:02 ET | DEF 14A | Proxy statementPeriod 2017-05-31 | 0001193125-17-148661 |
| 2017-03-2420:09 ET | 8-K | 8.01 Other events | 0001193125-17-095581 |
| 2017-03-0120:51 ET | 10-K | Annual reportPeriod 2016-12-31 | 0000855658-17-000012 |
| 2017-02-2818:44 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-17-061477 |
| 2017-02-1521:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-17-000010 |
| 2017-02-0622:02 ET | 8-K | 8.01 Other events | 0001193125-17-031906 |
| 2016-11-1022:07 ET | 10-Q | Quarterly reportPeriod 2016-10-01 | 0000855658-16-000309 |
| 2016-11-0721:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-16-000303 |
| 2016-11-0420:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-760269 |
| 2016-11-0420:09 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-16-760170 |
| 2016-11-0312:18 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-16-758100 |
| 2016-11-0312:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-758097 |
| 2016-11-0312:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-758079 |
| 2016-10-0315:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001123292-16-002789 |
| 2016-09-2715:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001123292-16-002782 |
| 2016-09-2220:45 ET | 8-K | 2.06 Material impairments | 0000855658-16-000289 |
| 2016-09-0913:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001123292-16-002694 |
| 2016-08-1119:00 ET | 10-Q | Quarterly reportPeriod 2016-07-02 | 0000855658-16-000282 |
| 2016-08-0920:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-16-000276 |
| 2016-07-0717:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000855658-16-000267 |
| 2016-05-1620:41 ET | 8-K | 5.07 Shareholder vote results | 0000855658-16-000251 |
| 2016-05-1218:27 ET | 10-Q | Quarterly reportPeriod 2016-04-02 | 0000855658-16-000231 |
| 2016-05-0920:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-16-000211 |
| 2016-05-0913:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001123292-16-002230 |
| 2016-04-2913:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001123292-16-002187 |
| 2016-04-2018:24 ET | DEF 14A | Proxy statementPeriod 2016-01-02 | 0000855658-16-000205 |
| 2016-04-1313:42 ET | SC 13D | Ownership report, active investor | 0001123292-16-002087 |
| 2016-03-0421:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000855658-16-000182 |
| 2016-03-0222:24 ET | 10-K | Annual reportPeriod 2016-01-02 | 0000855658-16-000180 |
| 2016-02-1721:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-16-000178 |
| 2015-11-1220:49 ET | 10-Q | Quarterly reportPeriod 2015-10-03 | 0000855658-15-000152 |
| 2015-11-1021:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000855658-15-000146 |
| 2015-11-0217:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-15-000144 |
| 2015-10-2920:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-15-000142 |
| 2015-10-1420:05 ET | 8-K | 2.05 Exit or disposal costs | 0000855658-15-000140 |
| 2015-08-1316:59 ET | 10-Q | Quarterly reportPeriod 2015-07-04 | 0000855658-15-000120 |
| 2015-07-3020:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-15-000116 |
| 2015-05-2620:54 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000855658-15-000098 |
| 2015-05-1521:26 ET | 10-Q | Quarterly reportPeriod 2015-04-04 | 0000855658-15-000091 |
| 2015-05-1221:14 ET | 8-K | 5.07 Shareholder vote results | 0000855658-15-000080 |
| 2015-05-0420:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-15-000058 |
| 2015-04-0717:50 ET | DEF 14A | Proxy statementPeriod 2015-01-03 | 0000855658-15-000055 |
| 2015-03-1120:34 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-15-087440 |
| 2015-03-0421:12 ET | 10-K | Annual reportPeriod 2015-01-03 | 0000855658-15-000035 |
| 2015-02-1811:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-15-051447 |
| 2015-02-0322:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-15-000015 |
| 2015-02-0321:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000855658-15-000010 |
| 2015-01-2714:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-15-021128 |
| 2015-01-2714:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-15-021123 |
| 2015-01-2711:43 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-15-020996 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:34 ET. Listed shows no prices and gives no investment advice.